Home The Word Brain	My Amedeo FAQ Privacy About
	Chinese Coaching Already know some Chinese? Stay on track with structured, one-on-one coaching to make steady, long-term progress. By Meng Wu and BSK.

Dermatology

Free Subscription 26.01.2026 1 Am J Pathol 1 BMC Cancer 3 Cancer 5 Cancer Lett 1 Cancer Res 1 Intern Med 3 J Invest Dermatol 1 JAAPA 1 N Engl J Med 7 Plast Reconstr Surg 13 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Pathol

1. BAFFERT B, Schneider K, Wetzel A, Dal Zuffo L, et al
   Macrophages Are Critical Inducers of Bleomycin-Induced Fibrosis in a Systemic Scleroderma Model.
   Am J Pathol. 2026;196:460-478.
   PubMed         Abstract available
   
   

   
   BMC Cancer

2. LIU C, Wang R, Wang S, Liu S, et al
   Pregnancy-associated breast cancer: gestational weight gain impact and nomogram validation.
   BMC Cancer. 2025 Nov 29. doi: 10.1186/s12885-025-15292.
   PubMed         Abstract available
   
   

   
   Cancer

3. DILEO M, Oglesby S, Leung CH, Pauken KE, et al
   Retrospective analysis of cutaneous immune-related adverse events following checkpoint inhibitor therapy in melanoma patients reveals increased risk associated with the HLA-B*51:01 allele.
   Cancer. 2026;132:e70262.
   PubMed         Abstract available
   
   
4. QIU Y, Wu L, Cai W, Chen M, et al
   The evolution and prognostic impact of HER2-low, HER2-ultralow, and HER2-null status in HER2-negative early breast cancer: A pre- to post-neoadjuvant chemotherapy study.
   Cancer. 2026;132:e70269.
   PubMed         Abstract available
   
   
5. ZHAO J, Graetz I, Howard D, Yabroff KR, et al
   Federal and state policies regulating short-term limited-duration insurance plans and timely cancer treatment initiation.
   Cancer. 2026;132:e70190.
   PubMed         Abstract available
   
   

   
   Cancer Lett

6. LI J, Li Z, Zhang X, Zhang H, et al
   Histone lactylation bridges metabolic reprogramming with chromatin-immune crosstalk in triple-negative breast cancer.
   Cancer Lett. 2025;639:218227.
   PubMed         Abstract available
   
   
7. SAFAEI M, Li YC, Chen CY, Hsieh PH, et al
   Targeting ephrin receptor A10 with antibody-drug conjugates for breast cancer.
   Cancer Lett. 2025;639:218225.
   PubMed         Abstract available
   
   
8. YOU Y, Wei L, Dai M, Zhao G, et al
   BMP9 potentiates immunotherapy in triple-negative breast cancer by suppressing Tregs infiltration via the PRKDC-CCL2 axis.
   Cancer Lett. 2025;639:218175.
   PubMed         Abstract available
   
   
9. DUAN F, Zhang C, Wu Z, Zhuang L, et al
   Copper Orchestrates Triple-negative Breast Cancer Progression via the STEAP3-dependent CDK16-JAK1 Activation.
   Cancer Lett. 2025 Dec 1:218192. doi: 10.1016/j.canlet.2025.218192.
   PubMed         Abstract available
   
   
10. GROZA P, Kumari K, Esteva-Socias M, Schott J, et al
    Fibrillarin-dependent 2'-O-methylation modulates RPS28 ribosome incorporation and oncogenic translation.
    Cancer Lett. 2026;639:218124.
    PubMed         Abstract available
    
    

    
    Cancer Res

11. KREGER BT, Liang Y, Reilly NM, Spears ME, et al
    CFT1946 Is an Orally Available Brain-Penetrant BRAFV600-Mutant Degrader That Overcomes BRAF Inhibitor Resistance.
    Cancer Res. 2026;86:438-452.
    PubMed         Abstract available
    
    

    
    Intern Med

12. MIYAMOTO AT, Kumanogoh A, Nishide M
    Current Overview of Multi-omics Analyses in Microscopic Polyangiitis and Granulomatosis with Polyangiitis.
    Intern Med. 2026;65:226-232.
    PubMed         Abstract available
    
    

    
    J Invest Dermatol

13. BELPAIRE A, Demeyer A, Berrevoet D, Van Nieuwerburgh F, et al
    Downregulated Aryl Hydrocarbon Receptor Expression Is Linked with Increased IFN-gamma Production and Impaired Immune Checkpoint Upregulation in Vitiligo.
    J Invest Dermatol. 2026;146:393-404.
    PubMed         Abstract available
    
    
14. OKAMURA K, Arai Y, Kawaguchi J, Tsukada S, et al
    A Hairless Mouse Model for Vitiligo: Enhancing Preclinical Therapeutic Evaluation.
    J Invest Dermatol. 2026;146:374-382.
    PubMed         Abstract available
    
    
15. KHAN SG, Baghoomian W, Kuschal-Tauzon C, Tamura D, et al
    RNA Lariat-Debranching Enzyme (DBR1) Variations in Sabinas Brittle Hair Syndrome Form of Trichothiodystrophy: A Trichothiodystrophy-Causing Gene.
    J Invest Dermatol. 2026;146:432-441.
    PubMed         Abstract available
    
    

    
    JAAPA

16. WERT K, Andress B
    Perineural spread as the presenting symptom for cutaneous squamous cell carcinoma.
    JAAPA. 2026;39:32-35.
    PubMed         Abstract available
    
    

    
    N Engl J Med

17. TOLANEY SM, de Azambuja E, Kalinsky K, Loi S, et al
    Sacituzumab Govitecan plus Pembrolizumab for Advanced Triple-Negative Breast Cancer.
    N Engl J Med. 2026;394:354-366.
    PubMed         Abstract available
    
    

    
    Plast Reconstr Surg

18. AMAKIRI UO, Graziano FD, Levy J, Kim M, et al
    Assessing the Impact of Frailty on Patient-Reported Outcomes and Clinical Complications in 2-Stage Implant-Based Breast Reconstruction.
    Plast Reconstr Surg. 2026;157:215-225.
    PubMed         Abstract available
    
    
19. FU D, Zhao Y, Chen Y, Yu L, et al
    Factors Influencing Patient Satisfaction in Frontal Hairline Correction with Hair Transplantation: A Multicenter Retrospective Study.
    Plast Reconstr Surg. 2026;157:184e-196e.
    PubMed         Abstract available
    
    
20. ZONA EE, Thornton SM, Via EC, Burkard ME, et al
    Anticancer Agents and Their Impact on Breast Reconstruction: A Guide for Plastic Surgeons Based on Systematic Review and Expert Consensus.
    Plast Reconstr Surg. 2026;157:227-236.
    PubMed         Abstract available
    
    
21. KIM DK, Dugue D, Perez MT, Powell SD, et al
    Tissue Expander Salvage after Postoperative Infection Depending on Plane of Placement in Breast Reconstruction.
    Plast Reconstr Surg. 2026;157:148e-157e.
    PubMed         Abstract available
    
    
22. POSSO AN, Mustoe A, Tobin M, Yamin M, et al
    Recent Antibiotic Use and Surgical Site Infections in Tissue Expander-Based Breast Reconstruction: A Propensity Score-Matched Analysis.
    Plast Reconstr Surg. 2026;157:158e-165e.
    PubMed         Abstract available
    
    
23. GUTIERREZ SALAZAR M, Rakoczy P, Doherty C, Van Laeken N, et al
    A Clinical Prediction Model for Prognosticating Salvage of the Infected Implant in Alloplastic Breast Reconstruction.
    Plast Reconstr Surg. 2026;157:238-246.
    PubMed         Abstract available
    
    
24. JONCZYK MM, Dong G, Wareham C, Persing SM, et al
    Adapting Perspectives: Analyzing Dynamic Shifts in Breast Surgical Trends and Reconstructive Choices over 16 Years.
    Plast Reconstr Surg. 2026;157:166e-174e.
    PubMed         Abstract available
    
    

    
    PLoS One

25. KUMAR ARK, Shaji CS, Rajagopalan A, Bhattacharya S, et al
    Increased sensitivity of etoposide-treated breast cancer cells with an ATM inhibitor.
    PLoS One. 2026;21:e0340472.
    PubMed         Abstract available
    
    
26. YING K, Xue H, Du S, Wang X, et al
    Zwitterionic molecularly imprinted polymers for selective capillary microextraction of N1,N12-Diacetylspermine (DiAcSpm) from breast cancer.
    PLoS One. 2026;21:e0339776.
    PubMed         Abstract available
    
    
27. PAJAREEYAPHAN S, Thongsuksai P, Sriplung H, Wichaidit W, et al
    Trends in skin cancer incidence in Songkhla, Southern Thailand, 1989-2020: A population-based study on the impact of geographic variation.
    PLoS One. 2026;21:e0331635.
    PubMed         Abstract available
    
    
28. YE L, Yu G, Cheng Y, Fan L, et al
    DnaK supports intracellular persistence of Staphylococcus xylosus and confers mechanical resilience to a human breast cancer cell line.
    PLoS One. 2026;21:e0341069.
    PubMed         Abstract available
    
    
29. CHAVDA T, Lawal A, Sowunmi A, Adegboyega B, et al
    Validation and limitations of the distress thermometer in identifying depression among metastatic breast cancer patients in Nigeria: Methodological challenges in depression-specific screening validation.
    PLoS One. 2026;21:e0341221.
    PubMed         Abstract available
    
    
30. GALLARDO-ALBURQUEQUE LA, Quispe-Landeo Y, Chaname-Marin A, Uribe-Cavero LJ, et al
    External validation of the Meggitt-Wagner, Texas University, SINBAD, and Saint Elian classifications for predicting major amputation in patients with diabetes at a public hospital in Peru.
    PLoS One. 2026;21:e0327601.
    PubMed         Abstract available
    
    
31. LI H, Pemov A, Allaway R, Muir DF, et al
    Immortalization and characterization of Schwann cell lines derived from NF1-associated cutaneous neurofibromas.
    PLoS One. 2026;21:e0340183.
    PubMed         Abstract available
    
    
32. ABUALKEBASH H, Saleh RAA, Ertunc HM
    Explainable depth-wise and channel-wise fusion models for multi-class skin lesion classification.
    PLoS One. 2026;21:e0340901.
    PubMed         Abstract available
    
    
33. FILIPOV T, Teutsch B, Vass D, Budinszki B, et al
    Cryoablation for fibroadenoma with liquid nitrogen based system: A retrospective analysis of prospectively collected data.
    PLoS One. 2026;21:e0340969.
    PubMed         Abstract available
    
    
34. WARREN RB, Hunter HJA, Papp KA, Gordon KB, et al
    Clinical proof of concept for small molecule mediated inhibition of IL-17 in psoriasis.
    PLoS One. 2026;21:e0341049.
    PubMed         Abstract available
    
    
35. KANEKI M, Ohira C, Takahashi M, Fukuyama T, et al
    Preventive effect of bentonite against pyoderma via direct binding capability of staphylococci.
    PLoS One. 2026;21:e0341148.
    PubMed         Abstract available
    
    
36. POELHEKKEN K, Greuter MJW, Dorrius MD, de Bock GH, et al
    Influence of follow-up, screening age, interval, and compliance on overdiagnosis of ductal carcinoma in situ (DCIS): A modelling study.
    PLoS One. 2026;21:e0331821.
    PubMed         Abstract available
    
    
37. MAENO M, Ishida M, Tamagawa-Mineoka R, Takashima N, et al
    Cardiovascular risk among middle-aged Japanese adults with atopic dermatitis: A nested case-control study.
    PLoS One. 2026;21:e0341337.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Dermatology is free of charge.